New HHS-Sponsored Research Provides New Tool and Updated Guidance on Mass Chemical Decontamination

This second edition of the guidance, called Primary Response Incident Scene Management (PRISM), incorporates new scientific evidence exit disclaimer icon on emergency self-decontamination, hair decontamination, the interactions of chemicals with hair, and the effects of a combined decontamination strategy referred to as the “triple protocol.”

Primary Response Incident Scene Management (PRISM): Volume 3: Operational Guidance for Mass Casualty Disrobe and Decontamination

The salient features of mass patient disrobe and decontamination are presented in Volume 3, which aims to provide all Federal, State, Tribal and local first responders with a simple, readily accessible guide to critical aspects of the incident response processes.

Primary Response Incident Scene Management (PRISM): Volume 2: Tactical Guidance for Mass Casualty Disrobe and Decontamination

This document provides an overview of the processes involved in mass patient disrobe and decontamination and the rationale that underpins each process. The document does not include supporting technical information or potential challenges. Volume 2 has particular application in the training and exercising of first responders and officials involved with domestic preparedness and emergency management.

Primary Response Incident Scene Management (PRISM): Volume 1: Strategic Guidance for Mass Casualty Disrobe and Decontamination

Presents a review of best practices, collates available evidence and identifies areas that require further investigation. The document is relevant to senior incident responders (e.g., Incident Commanders) and those responsible for emergency planning and civil contingencies, as it describes the supporting technical information that underpins the rationale for each stage of disrobe and decontamination and highlights potential issues or challenges.

FDA, CDC, and CMS launch task force to help facilitate rapid availability of diagnostic tests during public health emergencies

The US Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC) and the Centers for Medicare and Medicaid Services (CMS) announced the launch of the Tri-Agency Task Force for Emergency Diagnostics. This task force has been created to help leverage the expertise of each agency to advance rapid development and deployment of diagnostic tests in clinical and public health laboratories during public health emergencies.

Ebola Responders Establish Emergency Operations Center

When the Government of the Democratic Republic of Congo declared an Ebola outbreak in the country’s Équateur Province on 8 May 2018, national and international offers for support and assistance came pouring in. Managing all these partners becomes a challenge in itself. WHO has increasingly been using one tool to streamline the response: a Public Health Emergency Operations Centre (PHEOC).

Ready or Not: Protecting the Public’s Health from Diseases, Disasters and Bioterrorism, 2019

This report examines the United States' level of public health emergency preparedness on a state-by-state basis using 10 priority indicators. Taken together, the indicators are a checklist of priority aspects of states’ readiness for public health emergencies.